Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

2 results about "Colistin Sulfate" patented technology

Colistin sulfate is stable, but colistimethate sodium is readily hydrolysed to a variety of methanesulfonated derivatives. Colistin sulfate and colistimethate sodium are eliminated from the body by different routes. With respect to Pseudomonas aeruginosa, colistimethate is the inactive prodrug of colistin. The two drugs are not interchangeable .

Florfenicol/colistin sulfate soluble powder and preparation method thereof

ActiveCN103550755AImprove synergistic antibacterial effectEasy to usePowder deliveryOrganic active ingredientsPyrrolidinonesPolyvinylpyrrolidone
The invention discloses a florfenicol / colistin sulfate soluble powder which is composed of the following components in percentage by weight: 5-20% of florfenicol, 2-20% of colistin sulfate, 0.5-2% of borax, 5-30% of citric acid, 0.1-2% of potassium bicarbonate, 7.5-30% of polyvinylpyrrolidone, 1-5% of poloxamer 188 and the balance of anhydrous glucose. The invention also discloses a preparation method of the soluble powder, which comprises the following steps: dissolving the polyvinylpyrrolidone in anhydrous ethanol, adding the florfenicol, citric acid, borax, potassium bicarbonate and poloxamer 188, evenly mixing, recovering the ethanol, drying, pulverizing, adding the colistin sulfate and anhydrous glucose, and evenly mixing. The soluble powder ensures that the two reagents simultaneously enter the organism and better display the synergic antibacterial action; the method is simple and convenient to operate, and enhances the production efficiency; and the anhydrous ethanol is recovered, so the method protects the environment and is suitable for industrial production.
Owner:HENAN SOAR VETERINARY PHARMA

Analogous CecroPinP1 antimicrobial peptide and application thereof

InactiveCN107746431AGrowth inhibitionPromote growthAntibacterial agentsPeptide/protein ingredientsBacteroidesEscherichia coli
The invention discloses a CecroPinP1-like antibacterial peptide and its application, belonging to the technical field of biochemistry and molecular biology. The CecroPinP1-like antimicrobial peptide consists of 21 amino acids, and its amino acid sequence is shown in SEQ ID NO:1. CecroPinP1-like antibacterial peptides can inhibit Escherichia coli, Streptococcus pneumoniae, Salmonella typhimurium, Clostridium perfringens type C, Staphylococcus aureus, Listeria monocytogenes, Pasteurella and other bacteria Compared with doxycycline hydrochloride, amoxicillin, colistin sulfate and other antibiotics, the antibacterial effect is relatively better, and compared with CecroPinP1 antimicrobial peptide, it has stronger antibacterial activity. The minimum inhibitory concentration (MIC) of the CecroPinP1-like antimicrobial peptide against Streptococcus pneumoniae reached 62.5 μg / mL. CecroPinP1-like antimicrobial peptides have good thermal stability, can promote the growth of livestock and poultry, and have good application prospects in the development of antibacterial drugs and animal husbandry.
Owner:GUANGZHOU JUNYA TECH APPL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products